DD246111A5 - Verfahren zur herstellung von 2-halogennicergolinen - Google Patents

Verfahren zur herstellung von 2-halogennicergolinen Download PDF

Info

Publication number
DD246111A5
DD246111A5 DD86291510A DD29151086A DD246111A5 DD 246111 A5 DD246111 A5 DD 246111A5 DD 86291510 A DD86291510 A DD 86291510A DD 29151086 A DD29151086 A DD 29151086A DD 246111 A5 DD246111 A5 DD 246111A5
Authority
DD
German Democratic Republic
Prior art keywords
halo
nicergoline
general formula
acid addition
addition salts
Prior art date
Application number
DD86291510A
Other languages
German (de)
English (en)
Inventor
Gabor Megyeri
Tibor Keve
Bela Stefko
Erik Bogsch
Janos Galambos
Anna Kassai
Ferenc Trischler
Eva Palosi
Dora Groo
Egon Karpati
Zsolt Szombathelyi
Laszlo Szoporny
Bela Kiss
Istvan Laszlovszky
Erzsebet Lapis
Original Assignee
�������@������@����������@����@��Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �������@������@����������@����@��Kk�� filed Critical �������@������@����������@����@��Kk��
Publication of DD246111A5 publication Critical patent/DD246111A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD86291510A 1985-06-21 1986-06-20 Verfahren zur herstellung von 2-halogennicergolinen DD246111A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU852447A HU193782B (en) 1985-06-21 1985-06-21 Process for producing 2-halogeno-nicergoline derivatives and acid additional salts thereof

Publications (1)

Publication Number Publication Date
DD246111A5 true DD246111A5 (de) 1987-05-27

Family

ID=10959403

Family Applications (1)

Application Number Title Priority Date Filing Date
DD86291510A DD246111A5 (de) 1985-06-21 1986-06-20 Verfahren zur herstellung von 2-halogennicergolinen

Country Status (30)

Country Link
US (1) US4753949A (es)
JP (1) JPS62485A (es)
CN (1) CN1015365B (es)
AR (1) AR241533A1 (es)
AT (1) AT390614B (es)
AU (1) AU594686B2 (es)
BE (1) BE904957A (es)
CH (1) CH671018A5 (es)
CS (1) CS255875B1 (es)
DD (1) DD246111A5 (es)
DE (1) DE3620647A1 (es)
DK (1) DK292086A (es)
ES (1) ES8800953A1 (es)
FI (1) FI84605C (es)
FR (1) FR2583756B1 (es)
GB (1) GB2176788B (es)
HU (1) HU193782B (es)
IL (1) IL79179A0 (es)
IN (1) IN163116B (es)
IT (1) IT1204865B (es)
LU (1) LU86485A1 (es)
NL (1) NL8601612A (es)
NO (1) NO164099C (es)
PH (1) PH24732A (es)
PL (1) PL147390B1 (es)
PT (1) PT82808B (es)
SE (1) SE463716B (es)
SU (1) SU1445557A3 (es)
YU (1) YU107986A (es)
ZA (1) ZA864633B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU193781B (en) * 1985-06-21 1987-11-30 Richter Gedeon Vegyeszet Process for producing 10alpha-methoxy-6-methylergoline derivatives and acid additional salts thereof
HU196394B (en) * 1986-06-27 1988-11-28 Richter Gedeon Vegyeszet Process for preparing 2-halogenated ergoline derivatives

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3228943A (en) * 1962-06-11 1966-01-11 Lumilysergol derivatives
US3879554A (en) * 1970-03-20 1975-04-22 Farmaceutici Italia Use of 1,6-dimethyl-8-{62 -(5-bromonicotinoyloxymethyl)-10 {60 -methoxyergoline in treating cerebral and peripheral metabolic vascular disorders
US4199579A (en) * 1975-03-14 1980-04-22 Siphar S. A. Carbamates of 2-haloergolines and 2-haloergolenes and process for the preparation thereof
GB1513322A (en) * 1976-01-09 1978-06-07 Farmaceutici Italia Heterocyclic ergoline derivatives
YU39278B (en) * 1976-12-22 1984-10-31 Lek Tovarna Farmacevtskih Process for preparing 5-bromo nicotinic acid esters
IT1094965B (it) * 1978-04-05 1985-08-10 Corvi Mora E Procedimento di preparazione di derivati del lisergolo
DE91652T1 (de) * 1982-04-13 1984-03-29 Farmitalia Carlo Erba S.p.A., 20159 Milano Ergolinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
CH649998A5 (de) * 1982-08-09 1985-06-28 Sandoz Ag Ergolinderivate, ein verfahren zu ihrer herstellung und heilmittel, enthaltend diese ergolinderivate als wirkstoff.
GB8612366D0 (en) * 1986-05-21 1986-06-25 Erba Farmitalia Ergoline esters
GB8615471D0 (en) * 1986-06-25 1986-07-30 Erba Farmitalia T-butyl ergoline derivatives

Also Published As

Publication number Publication date
FI862635A (fi) 1986-12-22
DK292086A (da) 1986-12-22
AT390614B (de) 1990-06-11
SE8602737D0 (sv) 1986-06-19
JPS62485A (ja) 1987-01-06
IL79179A0 (en) 1986-09-30
IT1204865B (it) 1989-03-10
FR2583756A1 (fr) 1986-12-26
DK292086D0 (da) 1986-06-20
SU1445557A3 (ru) 1988-12-15
CN86104086A (zh) 1986-12-17
IN163116B (es) 1988-08-13
LU86485A1 (de) 1986-12-02
SE8602737L (sv) 1986-12-22
PH24732A (en) 1990-10-01
DE3620647A1 (de) 1987-01-02
FI84605B (fi) 1991-09-13
NO164099B (no) 1990-05-21
NO862493L (no) 1986-12-22
NO164099C (no) 1990-08-29
CH671018A5 (es) 1989-07-31
ZA864633B (en) 1987-02-25
PL147390B1 (en) 1989-05-31
AR241533A1 (es) 1992-08-31
HU193782B (en) 1987-11-30
SE463716B (sv) 1991-01-14
NO862493D0 (no) 1986-06-20
ATA168486A (de) 1989-11-15
US4753949A (en) 1988-06-28
GB2176788A (en) 1987-01-07
FI84605C (fi) 1991-12-27
ES8800953A1 (es) 1987-12-16
FI862635A0 (fi) 1986-06-19
GB8615120D0 (en) 1986-07-23
JPH0529227B2 (es) 1993-04-28
CS255875B1 (en) 1988-03-15
HUT41024A (en) 1987-03-30
AU5891686A (en) 1986-12-24
ES556359A0 (es) 1987-12-16
YU107986A (en) 1988-04-30
IT8620873A0 (it) 1986-06-20
NL8601612A (nl) 1987-01-16
FR2583756B1 (fr) 1990-01-12
PT82808B (pt) 1988-04-21
PT82808A (en) 1986-07-01
AU594686B2 (en) 1990-03-15
CN1015365B (zh) 1992-02-05
BE904957A (fr) 1986-12-19
GB2176788B (en) 1989-07-26

Similar Documents

Publication Publication Date Title
EP0207331B1 (de) Neue feste Formen von 2-Äthoxy-4-[N-(1-(2-piperidino-phenyl)-3-methyl-1-butyl)-aminocarbonylmethyl]-benzoesäure, diese Formen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE3001328C2 (es)
DE2516025A1 (de) Neue pyridinderivate, ihre herstellung und verwendung
DE2858726C2 (de) Arzneimittel zur senkung des serumcholesterinspiegels
DD235259A5 (de) Verfahren zur herstellung von 5,11-dihydro-11-[[(1-methyl-4-piperidinyl)amino]carbonyl]-6 h-dibenz[b,e]azepin-6-on und dessen salzen
DE2624789C3 (es)
EP0405298B1 (de) Thienopyran-Derivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung
DE2557145C3 (de) Tyrosinderivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE69819340T2 (de) Optisch reine camptothecinanaloge, optisch reines synthese-zwischenprodukt und verfahren zu ihrer herstellung
DD246111A5 (de) Verfahren zur herstellung von 2-halogennicergolinen
DE2632118A1 (de) Apovincaminolester und verfahren zu deren herstellung
DE3512629C2 (de) s-Triazolo[1,5-a]pyrimidine und Verfahren zu ihrer Herstellung
DE2716172C2 (de) Bis(6-[(hexahydro-1H-azepin-1-yl)-methylenamino]-penicillanoyloxy)-methan, seine Herstellung und dieses enthaltendes Arzneimittel
DE1595870C3 (de) Verfahren zur Herstellung von 3-(o-Methoxyphenoxy)-1,2-propandiolnicotinaten und deren Säureadditionssalzen
DE3619617A1 (de) Verfahren zur herstellung von 2-brom-(alpha)-ergokryptin
DE2520131A1 (de) Stickstoffhaltige polycyclische verbindungen und verfahren zu deren herstellung
DE2701417A1 (de) Pharmazeutische zubereitungen enthaltend sandwicin, isosandwicin oder neue derivate davon, diese neuen derivate und verfahren zu ihrer herstellung
LV11321B (en) Isopropyl-(2-methoxyethyl)-4-(2-chloro-3-cyano-phenyl)-1,4-dihydro-2,6-dimethyl-pyridine-3,5-dicarboxylate
DD290887A5 (de) Neue rifamycinderivate
DE3119514C2 (es)
DE3620487A1 (de) 10(alpha)-methoxy-6-methlergolin-derivate, verfahren zu deren herstellung und arzneimittelpraeparate
DE3109532C2 (de) Stereoisomere 1,4;3,6-Dianhydro-2,5-diazido-2,5-didesoxyhexite, Verfahren zur Herstellung derselben und diese Verbindungen enthaltende Arzneimittel
DE2425663A1 (de) Cyclodextrinderivate sowie verfahren zu ihrer herstellung
AT214455B (de) Verfahren zur Herstellung von neuen phosphorhaltigen Indolderivaten
DE2531108A1 (de) Vincaminderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee